TWO SIGMA INVESTMENTS, LP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$23,000
-84.8%
41,091
-69.6%
0.00%
Q1 2022$151,000
-80.0%
135,101
-73.9%
0.00%
-100.0%
Q4 2021$756,000
-4.7%
517,808
+96.0%
0.00%0.0%
Q3 2021$793,000
+6.6%
264,216
+64.9%
0.00%0.0%
Q2 2021$744,000
+2.3%
160,273
+32.2%
0.00%0.0%
Q1 2021$727,000
+634.3%
121,239
+960.2%
0.00%
Q2 2020$99,000
-60.6%
11,436
-67.1%
0.00%
-100.0%
Q4 2019$251,00034,7660.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders